Andrology
Alongside men in every phase of their reproductive health, from supporting fertility and hormonal balance to promoting vitality and wellbeing. Our commitment lies in helping men rediscover strength and confidence through science that truly cares.
Products
- Andrositol
- Andrositol Plus
- Xyminal
- Ialos
- Pervistop
- Pervistop Foam
- Biguanelle Gel
Infertility
Infertility
Infertility affects approximately 15% of couples worldwide, and in 20–70% of cases, a male factor is involved—either as the sole cause, in idiopathic infertility, when both partners are affected, or in cases of recurrent miscarriage.
This growing burden has led to what is often described as the “Male Fertility Crisis.” Over the past decades, research has shown a more than 50% decline in sperm counts since the mid-1970s, accompanied by reductions in other semen quality parameters. Today, it is estimated that over 30 million men suffer from infertility globally, with numbers expected to rise if current trends continue.
Semen abnormalities such as oligospermia (sperm count < 15 million/ml), asthenospermia (total motility < 40% or progressive motility < 32%), and teratospermia (normal morphology < 4%) are major contributors to reduced male fertility.
The combination of these three—known as OAT syndrome (oligo-astheno-teratospermia)—is among the most common causes of male infertility. In 30–45% of cases, the underlying mechanism remains idiopathic, with no identifiable cause. Importantly, poor sperm quality can also compromise the success rates of assisted reproductive technologies (ART), making early assessment and intervention crucial for reproductive outcomes.
